Novel relationships between oxidative stress and angiogenesis-related factors in sepsis: New biomarkers and therapies

References

• Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007;335:879–83.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.
   PubMed Web of Science ®Google Scholar
• Vincent JL. Clinical sepsis and septic shock—definition, diagnosis and management principles. Langenbecks Arch Surg. 2008;393:817–24.
   PubMed Web of Science ®Google Scholar
• Barie PS, Hydo LJ, Pieracci FM, Shou J, Eachempati SR. Multiple organ dysfunction syndrome in critical surgical illness. Surg Infect (Larchmt). 2009;10:369–77.
   PubMed Web of Science ®Google Scholar
• Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis. 2005;41:S490–7.
   PubMed Web of Science ®Google Scholar
• Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007;170: 1435–44.
   PubMed Web of Science ®Google Scholar
• Slade E, Tamber PS, Vincent JL. The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care. 2003;7:1–2.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Saa D, Galleguillos F, Céspedes C. Septic shock: clinical diagnosis and risk factors. In: Johnston MC, Knight JE, editors. Septic shock: symptoms, management and risk factors. 1st ed. pp. 51–74. Hauppage, NY: Nova Science Publishers; 2012.
   Google Scholar
• Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med. 2011;12: 165–73.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Matsukawa A. Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Pat Inflamm Allergy Drug Discov. 2009;3:26–32.
   PubMedGoogle Scholar
• Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth. 2003;90:221–32.
   PubMed Web of Science ®Google Scholar
• Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med. 1996;17:175–81.
   PubMed Web of Science ®Google Scholar
• Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM 2nd, Buchman TG, et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA. 2002;287:1716–21.
   PubMed Web of Science ®Google Scholar
• Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–77.
   PubMed Web of Science ®Google Scholar
• Boisramé-Helms J, Kremer H, Schini-Kerth V, Meziani F. Endothelial dysfunction in sepsis. Curr Vasc Pharmacol. 2013;11:150–60.
   PubMed Web of Science ®Google Scholar
• Alouf JE, Müller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol. 2003;292:429–40.
   PubMed Web of Science ®Google Scholar
• Christaki E, Giamarellos-Bourboulis EJ. The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet. 2014; 86:56–61.
   PubMed Web of Science ®Google Scholar
• Karapetsa M, Pitsika M, Goutzourelas N, Stagos D, Tousia Becker A, Zakynthinos E. Oxidative status in ICU patients with septic shock. Food Chem Toxicol. 2013;61:106–11.
   PubMed Web of Science ®Google Scholar
• von Dessauer B, Bongain J, Molina V, Quilodrán J, Castillo R, Rodrigo R. Oxidative stress as a novel target in pediatric sepsis management. J Crit Care. 2011;26:103.e1–7.
   PubMed Web of Science ®Google Scholar
• Andrades MÉ, Morina A, Spasić S, Spasojević I. Bench-to-bedside review: sepsis - from the redox point of view. Crit Care. 2011;15:230.
   PubMed Web of Science ®Google Scholar
• Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014;2014:761264.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004;18:1791–800.
   PubMed Web of Science ®Google Scholar
• Jones SA, O’Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OT. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 1996;271(4 Pt 2):H1626–34.
   PubMed Web of Science ®Google Scholar
• Granger DN, Stokes KY, Shigematsu T, Cerwinka WH, Tailor A, Krieglstein CF. Splanchnic ischaemia-reperfusion injury: mechanistic insights provided by mutant mice. Acta Physiol Scand. 2001;173: 83–91.
   PubMedGoogle Scholar
• Yang Y, Bazhin AV, Werner J, Karakhanova S. Reactive oxygen species in the immune system. Int Rev Immunol. 2013;32:249–70.
   PubMed Web of Science ®Google Scholar
• Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107:57–64.
   PubMed Web of Science ®Google Scholar
• Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176–80.
   PubMed Web of Science ®Google Scholar
• Araneda OF, Tuesta M. Lung oxidative damage by hypoxia. Oxid Med Cell Longev. 2012;2012:856918.
   PubMed Web of Science ®Google Scholar
• Schumacker PT. Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in triggering responses. Proc Am Thorac Soc. 2011;8:477–84.
   PubMedGoogle Scholar
• Li Q, Zhang Y, Marden JJ, Banfi B, Engelhardt JF. Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem J. 2008;411:531–41.
   PubMed Web of Science ®Google Scholar
• Hecker M, Cattaruzza M, Wagner AH. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Gen Pharmacol. 1999;32:9–16.
   PubMedGoogle Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
   PubMed Web of Science ®Google Scholar
• Millar TM, Phan V, Tibbles LA. ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase- dependent neutrophil recruitment. Free Radic Biol Med. 2007;42: 1165–77.
   PubMed Web of Science ®Google Scholar
• Van Houten B, Woshner V, Santos JH. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst). 2006;5:145–52.
   PubMed Web of Science ®Google Scholar
• Fredriksson K, Hammarqvist F, Strigård K, Hultenby K, Ljungqvist O, Wernerman J, et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab. 2006;291: E1044–50.
   PubMed Web of Science ®Google Scholar
• Finocchietto PV, Franco MC, Holod S, Gonzalez AS, Converso DP, Antico Arciuch VG, et al. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood). 2009;234:1020–8.
   PubMed Web of Science ®Google Scholar
• Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 1995;369: 136–9.
   PubMed Web of Science ®Google Scholar
• Franco MC, Antico Arciuch VG, Peralta JG, Galli S, Levisman D, López LM, et al. Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric-oxide synthase. J Biol Chem. 2006;281:4779–86.
   PubMed Web of Science ®Google Scholar
• Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv. 2005;5:94–111.
   PubMed Web of Science ®Google Scholar
• Garrabou G, Morén C, López S, Tobías E, Cardellach F, Miró O, et al. The effects of sepsis on mitochondria. J Infect Dis. 2012;205: 392–400.
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749–55.
   PubMed Web of Science ®Google Scholar
• Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12:919–24.
   PubMed Web of Science ®Google Scholar
• Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983–92.
   PubMed Web of Science ®Google Scholar
• De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5:73–9.
   PubMed Web of Science ®Google Scholar
• Nencioni A, Trzeciak S, Shapiro NI. The microcirculation as a diagnostic and therapeutic target in sepsis. Intern Emerg Med. 2009; 4:413–18.
   PubMed Web of Science ®Google Scholar
• Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med. 2002;346:1999–2001.
   PubMed Web of Science ®Google Scholar
• Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun. 1999;263:681–4.
   PubMed Web of Science ®Google Scholar
• Kaymak C, Basar H, Sardas S. Reactive oxygen species (Ros) generation in sepsis. FABAD J Pharm Sci. 2011;36:41–7.
   Google Scholar
• Bateman RM, Tokunaga C, Kareco T, Dorscheid DR, Walley KR. Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. Am J Physiol Heart Circ Physiol. 2007; 293:H448–56.
   PubMed Web of Science ®Google Scholar
• Wester T, Häggblad E, Awan ZA, Barratt-Due A, Kvernebo M, Halvorsen PS, et al. Assessments of skin and tongue microcirculation reveals major changes in porcine sepsis. Clin Physiol Funct Imaging. 2011;31:151–8.
   PubMed Web of Science ®Google Scholar
• Hernandez G, Boerma EC, Dubin A, Bruhn A, Koopmans M, Edul VK, et al. Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients. J Crit Care. 2013;28:538.e9–14.
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Arnold R, Sherwin R, O’Connor J, Najarro G, Singh S, et al. The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care. 2011;15:R223.
   PubMed Web of Science ®Google Scholar
• Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 2002;9(2 Suppl):36–44.
   PubMedGoogle Scholar
• Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res. 2006;53:89–103.
   PubMed Web of Science ®Google Scholar
• Mankhambo LA, Banda DL; IPD Study Group, Jeffers G, White SA, Balmer P, Nkhoma S, et al. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care. 2010;14:R91.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis and non-sepsis related hypotension. Shock. 2011;36:104–8.
   PubMed Web of Science ®Google Scholar
• van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock. 2005;23:35–8.
   PubMed Web of Science ®Google Scholar
• David S, van Meurs M, Kümpers P. Does low angiopoietin-1 predict adverse outcome in sepsis? Crit Care. 2010;14:180.
   PubMed Web of Science ®Google Scholar
• Jesmin S, Wada T, Gando S, Sultana SS, Zaedi S. The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis. Inflammation. 2013;36:186–96.
   PubMed Web of Science ®Google Scholar
• Novotny NM, Lahm T, Markel TA, Crisostomo PR, Wang M, Wang Y, et al. Angiopoietin-1 in the treatment of ischemia and sepsis. Shock. 2009;31:335–41.
   PubMed Web of Science ®Google Scholar
• Zhang RY, Zhang H, Huang J, Qu HP, Tang YQ. Angiogenic factors in sepsis: are we ready for the new therapeutic era? Crit Care. 2014;18:403.
   PubMed Web of Science ®Google Scholar
• Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009;101:36–47.
   PubMed Web of Science ®Google Scholar
• O’Brien A, Stidwill RP, Clapp LH, Singer M. Variable effects of inhibiting iNOS and closing the vascular ATP-sensitive potassium channel (via its pore-forming and sulfonylurea receptor subunits) in endotoxic shock. Shock. 2009;31:535–41.
   PubMed Web of Science ®Google Scholar
• Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586–92.
   PubMed Web of Science ®Google Scholar
• Karlsson S, Pettila V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E, et al. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg. 2008;106:1820–6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Song S-D, Wang H-X. [A clinical study of the serum vascular endothelial growth factor in patients with severe sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:172–4.
   PubMedGoogle Scholar
• Yano K, Okada Y, Beldi G, Shih SC, Bodyak N, Okada H, et al. Elevated levels of placental growth factor represent an adaptive host response in sepsis. J Exp Med. 2008;205:2623–31.
   PubMed Web of Science ®Google Scholar
• Zepeda AB, Pessoa A Jr, Castillo RL, Figueroa CA, Pulgar VM, Farías JG. Cellular and molecular mechanisms in the hypoxic tissue: role of HIF-1 and ROS. Cell Biochem Funct. 2013;31:451–9.
   PubMed Web of Science ®Google Scholar
• Kim YW, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625–31.
   PubMed Web of Science ®Google Scholar
• Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock. 2005;24:508–12.
   PubMed Web of Science ®Google Scholar
• Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers. 2011;16:11–21.
   PubMed Web of Science ®Google Scholar
• Ziegler T, Horstkotte J, Schwab C, Pfetsch V, Weinmann K, Dietzel S, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest. 2013;123:3436–45.
   Web of Science ®Google Scholar
• Gibot S, Lévy B, Nevière R, Cariou A, Lesur O. Myocardial dysfunction and septic shock. Med Sci (Paris). 2004;20:1115–18.
   PubMed Web of Science ®Google Scholar
• Métais C, Wiel E, Vallet B. Role of endothelial dysfunction in sepsis mortality. Therapie. 2004;59:31–40.
   PubMed Web of Science ®Google Scholar
• Reid VL, Webster NR. Role of microparticles in sepsis. Br J Anaesth. 2012;109:503–13.
   PubMed Web of Science ®Google Scholar
• Manoilescu I, Teleman S, Cojocaru E, Mihăilă D, Plămădeală P. Vascular endothelial growth factor (VEGF) expression in the lung in toxic septic shock. Rom J Morphol Embryol. 2011;52:309–13.
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol. 2006;290: L209–21.
   PubMed Web of Science ®Google Scholar
• Cardinal-Fernández P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F, Martín-Pellicer A, et al. Genetic predisposition to acute kidney injury induced by severe sepsis. J Crit Care. 2013;28: 365–70.
   PubMed Web of Science ®Google Scholar
• Moreau R, Arroyo V. Acute on chronic liver failure: a new clinical entity. Clin Gastroenterol Hepatol. 2014 Feb 28. [Epub ahead of print]
   Google Scholar
• Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1.
   PubMed Web of Science ®Google Scholar
• Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2009;37:S331.
   PubMedGoogle Scholar
• León C, Loza A. Sepsis biomarkers. Simplifying the complex? Enferm Infecc Microbiol Clin. 2014;32:137–9.
   PubMed Web of Science ®Google Scholar
• Atkinson AJ Jr, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69: 89–95.
   PubMed Web of Science ®Google Scholar
• Julián-Jiménez A, Candel-González FJ, González del Castillo J. [Usefulness of inflammation and infection biomarkers in the Emergency Department]. Enferm Infecc Microbiol Clin. 2014;32: 177–90. [In Spanish]
   PubMed Web of Science ®Google Scholar
• Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.
   PubMed Web of Science ®Google Scholar
• Nelson GE, Mave V, Gupta A. Biomarkers for sepsis: a review with special attention to India. Biomed Res Int. 2014;2014:264351.
   PubMed Web of Science ®Google Scholar
• Walley KR. Biomarkers in sepsis. Curr Infect Dis Rep. 2013;15: 413–20.
   PubMed Web of Science ®Google Scholar
• Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23–36.
   PubMed Web of Science ®Google Scholar
• Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351:17–29.
   PubMed Web of Science ®Google Scholar
• Charles PE, Gibot S. Predicting outcome in patients with sepsis: new biomarkers for old expectations. Crit Care. 2014;18:108.
   PubMed Web of Science ®Google Scholar
• Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40:358–65.
   PubMed Web of Science ®Google Scholar
• Cho SY, Choi JH. Biomarkers of sepsis. Infect Chemother. 2014;46:1–12.
   PubMedGoogle Scholar
• Borthwick HA, Brunt LK, Mitchem KL, Chaloner C. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem. 2012;49:391–4.
   PubMed Web of Science ®Google Scholar
• Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnosis and biomarkers. Clin Microbiol Rev. 2012;25:609–34.
   PubMed Web of Science ®Google Scholar
• Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis. 2006;17:445–51.
   PubMed Web of Science ®Google Scholar
• Bernal ME, Varon J, Acosta P, Montagnier L. Oxidative stress in critical care medicine. Int J Clin Pract. 2010;64:1480–8.
   PubMed Web of Science ®Google Scholar
• Lorente L, Martín MM, Abreu-González P, Domínguez-Rodriguez A, Labarta L, Díaz C, et al. Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients. Crit Care. 2013;17:R290.
   PubMed Web of Science ®Google Scholar
• Ware LB, Fessel JP, May AK, Roberts LJ 2nd. Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock. 2011;36:12–17.
   PubMed Web of Science ®Google Scholar
• Kothari N, Keshari RS, Bogra J, Kohli M, Abbas H, Malik A, et al. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J Crit Care. 2011;26: 435.e1–7.
   PubMed Web of Science ®Google Scholar
• Forceville X, Mostert V, Pierantoni A, Vitoux D, Le Toumelin P, Plouvier E, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res. 2009;43:338–47.
   PubMed Web of Science ®Google Scholar
• Mishra V, Baines M, Wenstone R, Shenkin A. Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem. 2005;42(Pt 4):269–76.
   PubMed Web of Science ®Google Scholar
• Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754–8.
   PubMed Web of Science ®Google Scholar
• Zhang RY, Liu YY, Qu HP, Tang YQ. The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both? Crit Care. 2013; 17:446.
   PubMed Web of Science ®Google Scholar
• Tsokos M, Pufe T, Paulsen F, Anders S, Mentlein R. Pulmonary expression of vascular endothelial growth factor in sepsis. Arch Pathol Lab Med. 2003;127:331–5.
   PubMed Web of Science ®Google Scholar
• Yang KY, Liu KT, Chen YC, Chen CS, Lee YC, Perng RP, et al. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study. Crit Care. 2011;15:R11.
   PubMed Web of Science ®Google Scholar
• Ostrowski S, Sørensen AM, Windeløv NA, Perner A, Welling K-L, Wanscher M, et al. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med. 2012; 20:27.
   PubMed Web of Science ®Google Scholar
• Skibsted S, Jones AE, Puskarich MA, Arnold R, Sherwin R, Trzeciak S, et al. Biomarkers of endothelial cell activation in early sepsis. Shock. 2013;39:427–32.
   PubMed Web of Science ®Google Scholar
• Smadja DM, Borgel D, Diehl JL, Gaussem P. Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure. J Thromb Haemost. 2012; 10:974–6.
   PubMed Web of Science ®Google Scholar
• Page AV, Liles WC. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013;4:507–16.
   PubMed Web of Science ®Google Scholar
• Davis JS, Weo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, et al. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care. 2010;14:R89.
   PubMed Web of Science ®Google Scholar
• Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, et al. Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome. Crit Care. 2012;16: R171.
   PubMed Web of Science ®Google Scholar
• Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011;39:702–10.
   PubMed Web of Science ®Google Scholar
• Raeven P, Salibasic A, Drechsler S, Weixelbaumer KM, Jafarmadar M, van Griensven M, et al. A non-lethal traumatic/hemorrhagic insult strongly modulates the compartment-specific PAI-1 response in the subsequent polymicrobial sepsis. PLoS One. 2013;8:e55467.
   PubMed Web of Science ®Google Scholar
• Xing K, Murthy S, Liles WC, Singh JM. Clinical utility of biomarkers of endothelial activation in sepsis- a systematic review. Crit Care. 2012;16:R7.
   PubMed Web of Science ®Google Scholar
• Wong HR, Lindsell CJ, Pettilä V, Meyer NJ, Thair SA, Karlsson S, et al. A multibiomarker-based outcome risk stratification model for adult septic shock. Crit Care Med. 2014;42:781–9.
   PubMed Web of Science ®Google Scholar
• Lehmann C, Sharawi N, Al-Banna N, Corbett N, Kuethe JW, Caldwell CC. Novel approaches to the development of anti-sepsis drugs. Expert Opin Drug Discov. 2014;9:523–31.
   PubMed Web of Science ®Google Scholar
• Mishra V. Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab. 2007;53:199–209.
   PubMed Web of Science ®Google Scholar
• Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al.; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368:1489–97.
   PubMed Web of Science ®Google Scholar
• Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012;16:R66.
   PubMed Web of Science ®Google Scholar
• Manzanares W, Langlois PL, Hardy G. Update on antioxidant micronutrients in the critically ill. Curr Opin Clin Nutr Metab Care. 2013;16:719–25.
   PubMed Web of Science ®Google Scholar
• Lane N. A unifying view of ageing and disease: the double-agent theory. J Theor Biol. 2003;225:531–40.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, et al. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem. 2004; 279:37575–87.
   PubMed Web of Science ®Google Scholar
• Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med. 2008;45:1559–65.
   PubMed Web of Science ®Google Scholar
• Macias CA, Chiao JW, Xiao J, Arora DS, Tyurina YY, Delude RL, et al. Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg. 2007;245:305–14.
   PubMed Web of Science ®Google Scholar
• Ospina-Tascon G, Neves AP, Occhipinti G, Donadello K, Büchele G, Simion D, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010;36:949–55.
   PubMed Web of Science ®Google Scholar
• Mittermayer F, Pleiner J, Schaller G, Zorn S, Namiranian K, Kapiotis S, et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005;289: H1752–7.
   PubMed Web of Science ®Google Scholar
• Tyml K, Li F, Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med. 2008;36:2355–62.
   PubMed Web of Science ®Google Scholar
• He X, Su F, Velissaris D, Salgado DR, de Souza Barros D, Lorent S, et al. Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shock. Crit Care Med. 2012;40:2833–40.
   PubMed Web of Science ®Google Scholar
• Tyml K, Li F, Wilson JX. Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med. 2005;33:1823–8.
   PubMed Web of Science ®Google Scholar
• Jeong SJ, Han SH, Kim CO, Choi JY, Kim JM. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care. 2013; 17:R97.
   PubMed Web of Science ®Google Scholar
• Kumpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park JK, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care. 2011;15:R261.
   PubMed Web of Science ®Google Scholar
• Austenaa LM, Carlsen H, Hollung K, Blomhoff HK, Blomhoff R. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J Nutr Biochem. 2009;20:726–34.
   PubMed Web of Science ®Google Scholar
• Durant R, Klouche K, Delbosc S, Morena M, Amigues L, Beraud JJ, et al. Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin. Shock. 2004;22:34–9.
   PubMed Web of Science ®Google Scholar
• Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem. 2012;56: 67–83.
   PubMedGoogle Scholar
• Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118–26.
   PubMed Web of Science ®Google Scholar
• Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci. 2010;1201: 96–103.
   PubMed Web of Science ®Google Scholar
• Smith RA, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem. 1999;263: 709–16.
   PubMedGoogle Scholar
• Mao G, Kraus GA, Kim I, Spurlock ME, Bailey TB, Beitz DC. Effect of a mitochondria-targeted vitamin E derivative on mitochondrial alteration and systemic oxidative stress in mice. Br J Nutr. 2011;106: 87–95.
   PubMed Web of Science ®Google Scholar
• Wipf P, Xiao J, Jiang J, Belikova NA, Tyurin VA, Fink MP, et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J Am Chem Soc. 2005;127:12460–1.
   PubMed Web of Science ®Google Scholar